For 5-amino-1MQ specifically: Preclinical studies have not prominently described heart rate elevation as a dominant signal The mechanism (NNMT inhibition, NAD+ preservation) does not have the same direct cardiac implications as nuclear receptor agonism Human cardiovascular data at clinically relevant exposures are limited For physicians, the current evidence base does not support a major cardiovascular safety flag, but the limited human dataset means confident statements are premature
Contraindications You should not receive MIC+B12 injections if you: Have a known allergy or hypersensitivity to any of the ingredients (e.g., methionine, inositol, choline, vitamin B12) or their preservatives
Hydration Dehydration is an underappreciated risk during this combination
This approach provides more actionable data for research environments and helps ensure that the results associated with a peptide product are scientifically relevant, transparent, and appropriate for laboratory research use
In german its versandapo, shows a union flag as shipping destination
